| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...736419L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0036419 |
| P932 | PMC publication ID | 3359319 |
| P698 | PubMed publication ID | 22649493 |
| P5875 | ResearchGate publication ID | 225079687 |
| P50 | author | Josué da Costa Lima-Junior | Q56555271 |
| Luis Cristovão Sobrino Porto | Q56600347 | ||
| Dalma M Banic | Q56816535 | ||
| Rodrigo Nunes Rodrigues-da-Silva | Q59690115 | ||
| John W Barnwell | Q60452505 | ||
| Alberto Moreno | Q68159699 | ||
| P2093 | author name string | Balwan Singh | |
| Jianlin Jiang | |||
| Esmeralda V S Meyer | |||
| Mary R Galinski | |||
| Maurício M Rodrigues | |||
| Joseli de Oliveira-Ferreira | |||
| Gustavo M Fabrício-Silva | |||
| P2860 | cites work | Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations | Q24612449 |
| Plasmodium vivax, P. cynomolgi, and P. knowlesi: identification of homologue proteins associated with the surface of merozoites | Q56379655 | ||
| Family-based association of HLA class II alleles and haplotypes with type I diabetes in Brazilians reveals some characteristics of a highly diversified population | Q60609056 | ||
| The presence of the HLA class II allele DPB1*0501 in ethnic Thais correlates with an enhanced vaccine-induced antibody response to a malaria sporozoite antigen | Q45157941 | ||
| Influence of HLA-DRB1 alleles on antibody responses to PfCP-2.9-immunized and naturally infected individuals. | Q46086616 | ||
| Evidence of HLA class II association with antibody response against the malaria vaccine SPF66 in a naturally exposed population | Q46230947 | ||
| Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria. | Q46339260 | ||
| MHC and malaria: the relationship between HLA class II alleles and immune responses to Plasmodium falciparum | Q46349176 | ||
| Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan. | Q46682906 | ||
| Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli. | Q47664368 | ||
| Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax | Q47852201 | ||
| Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparum | Q47872379 | ||
| Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax | Q47886636 | ||
| Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP119 expressed in distinct bacterial vectors | Q47893571 | ||
| Immunogenic properties of the Plasmodium vivax vaccine candidate MSP1(19) expressed as a secreted non-glycosylated polypeptide from Pichia pastoris | Q47902024 | ||
| Human leukocyte antigen class II control of the immune response to p126-derived amino terminal peptide from Plasmodium falciparum | Q47911320 | ||
| Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka | Q47986453 | ||
| HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malaria | Q47990902 | ||
| Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes | Q48013154 | ||
| Plasmodium vivax vaccine research: steps in the right direction | Q48019399 | ||
| Acquired immunity to malaria | Q24651173 | ||
| The pathogenic basis of malaria | Q29615020 | ||
| Plasmodium vivax merozoite surface proteins-3beta and-3gamma share structural similarities with P. vivax merozoite surface protein-3alpha and define a new gene family | Q30671058 | ||
| Plasmodium vivax merozoite surface protein-3 contains coiled-coil motifs in an alanine-rich central domain | Q30738627 | ||
| Malaria | Q33360939 | ||
| The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis | Q33526349 | ||
| The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation | Q33652505 | ||
| Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon. | Q33817378 | ||
| HLA DNA sequence variation among human populations: molecular signatures of demographic and selective events | Q33847355 | ||
| Different response to Plasmodium falciparum in west African sympatric ethnic groups: possible implications for malaria control strategies | Q33852128 | ||
| Malaria in Brazil: an overview | Q33939774 | ||
| Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant | Q34000050 | ||
| Interaction of HLA and age on levels of antibody to plasmodium falciparum rhoptry-associated proteins 1 and 2 | Q34003999 | ||
| A malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune response | Q34071439 | ||
| HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM. | Q34412690 | ||
| B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax Merozoite Surface Protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon | Q34726966 | ||
| HLA polymorphisms and evolution | Q35273813 | ||
| Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria | Q35546112 | ||
| Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals | Q35606249 | ||
| Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians | Q36313424 | ||
| Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria | Q36594057 | ||
| An update on the search for a Plasmodium vivax vaccine | Q36720449 | ||
| HLA-DR: molecular insights and vaccine design | Q36737531 | ||
| Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon | Q36835626 | ||
| Invasion of host cells by malaria parasites: a tale of two protein families | Q36881595 | ||
| Plasmodium vivax: who cares? | Q37018632 | ||
| Human leukocyte antigen class II alleles influence levels of antibodies to the plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1 | Q37426223 | ||
| Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species | Q37506803 | ||
| Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite | Q37583147 | ||
| Malaria vaccine development based on merozoite surface proteins of Plasmodium falciparum | Q37791332 | ||
| Malaria antigens and MHC restriction | Q38029415 | ||
| Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens | Q39829181 | ||
| Reverse immunogenetics: from HLA-disease associations to vaccine candidates | Q40958604 | ||
| Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1. | Q41923301 | ||
| Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101/ABRA of P. falciparum | Q43889939 | ||
| Interethnic differences in the humoral response to non-repetitive regions of the Plasmodium falciparum circumsporozoite protein. | Q43934996 | ||
| Analysis of the genetic variability of PvMSP-3α among Plasmodium vivax in Brazilian field isolates | Q44607051 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| Plasmodium vivax | Q311376 | ||
| P304 | page(s) | e36419 | |
| P577 | publication date | 2012-05-23 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area | |
| P478 | volume | 7 |
| Q35877857 | A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions |
| Q37314756 | A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119. |
| Q94491384 | A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria |
| Q37685993 | A systematic review on malaria sero-epidemiology studies in the Brazilian Amazon: insights into immunological markers for exposure and protection |
| Q37363110 | Cellular and humoral immune responses against the Plasmodium vivax MSP-1₁₉ malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil |
| Q48020555 | Enteroparasite and vivax malaria co-infection on the Brazil-French Guiana border: Epidemiological, haematological and immunological aspects |
| Q55364172 | Evaluating seroprevalence to circumsporozoite protein to estimate exposure to three species of Plasmodium in the Brazilian Amazon. |
| Q57285883 | Evaluation of Plasmodium vivax isolates in Thailand using polymorphic markers Plasmodium merozoite surface protein (PvMSP) 1 and PvMSP3 |
| Q34078790 | Evaluation of naturally acquired IgG antibodies to a chimeric and non-chimeric recombinant species of Plasmodium vivax reticulocyte binding protein-1: lack of association with HLA-DRB1*/DQB1* in malaria exposed individuals from the Brazilian Amazon. |
| Q36965601 | Immunogenetic markers associated with a naturally acquired humoral immune response against an N-terminal antigen of Plasmodium vivax merozoite surface protein 1 (PvMSP-1). |
| Q90224277 | Immunogenicity of synthetic peptide constructs based on PvMSP9E795-A808, a linear B-cell epitope of the P. vivax Merozoite Surface Protein-9 |
| Q34234390 | Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis |
| Q35898819 | In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9 |
| Q35947469 | Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera |
| Q36176223 | Influence of HLA-DRB1 Alleles on the Variations of Antibody Response to Tuberculosis Serodiagnostic Antigens in Active Tuberculosis Patients |
| Q38728598 | Insights into the naturally acquired immune response to Plasmodium vivax malaria |
| Q26767472 | Major Histocompatibility Complex and Malaria: Focus on Plasmodium vivax Infection |
| Q26772878 | Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria |
| Q37308698 | Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children |
| Q34744820 | Plasmodium vivax Merozoite Surface Protein-3 (PvMSP3): Expression of an 11 Member Multigene Family in Blood-Stage Parasites |
| Q36155071 | Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women |
| Q35931132 | Polymorphisms in B Cell Co-Stimulatory Genes Are Associated with IgG Antibody Responses against Blood-Stage Proteins of Plasmodium vivax |
| Q98611570 | Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon |
| Q46758381 | Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area |
| Q28545082 | The Plasmodium vivax merozoite surface protein 3β sequence reveals contrasting parasite populations in southern and northwestern Thailand |
| Q28396379 | The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic Variants |
| Q33792078 | The evolution and diversity of a low complexity vaccine candidate, merozoite surface protein 9 (MSP-9), in Plasmodium vivax and closely related species |
| Q55380572 | The in Vitro Antigenicity of Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2) B- and T-Epitopes Selected by HLA-DRB1 Binding Profile. |
| Q40919228 | The influence of intestinal parasites on Plasmodium vivax-specific antibody responses to MSP-119 and AMA-1 in rural populations of the Brazilian Amazon |
| Q35524269 | The origin and diversification of the merozoite surface protein 3 (msp3) multi-gene family in Plasmodium vivax and related parasites. |
| Q37638131 | What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates? |
Search more.